CD8A and neoplasm: 1. At high doses: Enhances the proliferation and cytotoxic activity of CD8+ T cells;2. Inhibits chronic inflammatory responses and reduces the occurrence of inflammation-related tumors;3. CmAb-IL10 fusion protein: Prevents DC-mediated tumor infiltration